- (HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
-
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.
- -
-
Page/Page column 141; 152; 153
(2013/05/09)
-
- Asymmetric cyclopropanation of vinyl fluorides: Access to enantiopure monofluorinated cyclopropane carboxylates
-
The transition metal catalyzed cyclopropanation with alkyl diazoacetates of aliphatic or aromatic vinyl fluorides, prepared from the corresponding alkenes by bromofluorination and subsequent dehydrobromination, provides a smooth access to racemic I:1 mixt
- Meyer,Froehlich,Haufe
-
p. 1479 - 1490
(2007/10/03)
-